Real-World EMEA Physician Preference Data1 Demonstrates the SOFIA Flow 88 Aspiration Catheter’s Trackability, Navigation, and Overall Performance in Stroke Procedures MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly…

Real-World U.S. Physician Preference Data1 Demonstrates the SOFIA™ 88 Catheter’s Trackability, Atraumatic Design, and Overall Performance in Stroke Procedures NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned…

Terumo Neuro’s SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility ALISO VIEJO, Calif., May 13, 2025 /PRNewswire/ — Terumo Neuro, a global…

More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking WEB™…